Alopecia Treatment Market

Alopecia Treatment Market Outlook (2022 to 2032)

Newly-released Alopecia Treatment Market analysis report by Future Market Insight shows that global sales of the Alopecia Treatment Market in 2021 were held at USD 8.4 Billion. With a CAGR of 9.5% from 2022 to 2032, the market is projected to reach a valuation of USD 22.5 Billion by 2032. The market through Alopecia Areata is expected to gross significant revenue, accounting for an expected CAGR rate of 9.5% from 2022 to 2032.

Attribute	Details
Global Alopecia Treatment Market (2022)	USD 9.1 Billion
Global Alopecia Treatment Market (2032)	USD 22.5 Billion
Global Alopecia Treatment Market CAGR (2022 to 2032)	9.5%
USA Alopecia Treatment Market (2022)	USD 2.8 Billion
Key Companies Profiled	iRestore Hair Growth System; iGrow Laser; Theradome; Curallux; Lexington Intl., LLC.; LUTRONIC

Revenue of Alopecia Treatment Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Alopecia Treatment Market research by Future Market Insight - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Alopecia Treatment Market increased at around 8.5% CAGR.

Demand for hair-restoration drugs, which often have improved efficacy and minimal side effects, has led to the development of the market for alopecia treatment. For example, cutting-edge treatments including cytokine therapy and regenerative cell therapy are becoming increasingly popular within the field of alopecia treatment.

Hair regrowth is enhanced by cytokine therapy, which causes hair follicle cells to differentiate and proliferate while controlling the hair growth cycle. Combination therapies have also been shown to be clinically effective in the treatment of Alopecia Treatment. Combination therapeutics are currently the most widely used hair loss treatment.

Increased focus on providing hair loss solutions (with both functional and active ingredients) with multifunctional effects, as well as increased penetration of advanced hair loss treatment therapies such as stem cell therapy, are set to define the market landscape of the hair loss industry over the forecast period.

The introduction of low-level laser therapy, which helps stimulate hair growth, is expected to boost the number of patients treated for hair loss. Furthermore, the introduction of laser caps, helmets, combs, and bands are expected to boost the market growth. Some of the technologically advanced products on the market include the Capillus Laser Cap, iGrow Laser Helmet, iRestore Hair Growth System, and Hairmax Laser devices.

How are the increasing initiatives and growing prevalence of Hair Loss fuelling the Alopecia Treatment Market?

An increase in healthcare spending is being driven by an increase in the number of initiatives being undertaken by organizations such as the National Alopecia Treatment Areata Foundation and the American Hair Loss Association to raise awareness about hair regrowth and treatment options.

The Affordable Care Act of 2010 allows people to purchase health insurance at a low cost, thereby benefiting patients who are financially disadvantaged. This led to an overall increase in treatment rates, driving the market growth. Furthermore, as people become more aware of hair loss, there is a greater demand for painless therapies with few side effects, which is driving up the treatment rate around the world.

The increase in the incidence of Alopecia Treatment is among the primary factors driving the market growth. In the USA in 2018, the American Academy of Dermatology Association (AAD) estimated that roughly Alopecia affected 50 million individuals and 30 million women, more than 50 million men, and 30 million women.

According to The Journal of Clinical and Diagnostic Research (JCDR)'s study, roughly 60% of the population suffers from hair loss, with various factors contributing to the severity of pattern hair loss in both sexes.

The prevalence of chronic diseases such as cancer, Polycystic Ovary Syndrome (PCOS), and rheumatoid arthritis, all of which are linked to the loss of hair, is expected to increase the demand for the treatment of hair loss in the near future. According to the Department of Health and Human Services of the USA, PCOS affects nearly 5 million individuals in the USA.

Which Region is projected to Offer the Largest Opportunity for Alopecia Treatment Market?

In 2021, North America was the largest market for Alopecia Treatment globally. It is because the country has an advanced healthcare infrastructure, a high disposable income, and a multitude of novel treatment options. Roughly one in 500 to 1,000 individuals are affected by alopecia areata in the USA, according to the National Library of Medicine. The second most common form of alopecia treatment after androgenic alopecia treatment is alopecia treatment areata, one of the most common kinds of alopecia treatment.

Country-wise Analysis

USA Alopecia Treatment Market Analysis

The USA is expected to account for the highest market share of USD 7.3 Billion by the end of 2032. Alopecia areata is a common autoimmune condition that causes sporadic hair loss. In the USA, it affects approximately 6.8 million people. Furthermore, the region's advanced healthcare infrastructure, combined with strict Alopecia Treatment requirements, is expected to accelerate the advancement of the market in the country.

China Alopecia Treatment Market Analysis

China dominates the Asia Pacific market with a CAGR of 10.9% having an absolute dollar growth opportunity of USD 1.9 Billion. As more consumers share the incidence of hair loss problems, cosmetic product manufacturers are introducing additional hair care products and drinks that target these individuals, leading to a rise in cosmetics spending in China.

The majority of consumers have consequently perceived the demand as well as the need for natural and organic products for personal hair care. Shampoo and conditioner accounted for the majority of the regional and global organic haircare market in 2019, owing to the massive use of these products.

In China, for instance, Henkel Beauty Care introduced the Schwarzkopf Extra Care Sun Repair Spray Conditioner in 2017, which boasts a highly effective formula combining Monoi Flower Extract and UVA/UVB filtering agents that repair and protect hair from sun and salt damage. Likewise, brand-endorsed hair care products, including conditioners, have gained immense popularity in China.

UK Alopecia Treatment Market Analysis

The market in the UK is projected to reach a valuation of USD 974 Million by 2032. Growing at a CAGR of 10.2%, the market in the country is projected to gross an absolute dollar opportunity of over USD 600 Million from 2022 to 2032.

Japan Alopecia Treatment Market Analysis

In Japan, the market is expected to reach USD 1.2 Billion by 2032, growing at a CAGR of 11.1% during the forecast period. During this period, the market is likely to gross an absolute dollar opportunity of USD 780 Million.

Category-wise Insights

What are the insights about Alopecia Revenue through Treatment Type and Sales Channel?

In 2021, the pharmaceutical segment dominated the Alopecia Treatment type. The segment is driven by the low cost of pharmaceutical products and the high use of prescription and over-the-counter drugs. The most common drugs used to treat Alopecia Treatment are Finasteride and Minoxidil.

Finasteride and Minoxidil are the only drugs approved in the USA to treat both Female Pattern Hair Loss (FPHL) and Male Pattern Hair Loss (MPHL) (MPHL). Furthermore, key pharmaceutical companies such as Lilly, Pfizer Inc., and Concert Pharmaceuticals are actively involved in the development of novel Alopecia Treatments, which is expected to drive the market over the forecast period.

Due to the high number of visits to dermatologists for hair loss treatment, the prescription segment dominated the market and accounted for the largest revenue share in 2021. According to the National Library of Medicine, approximately 2.6 million outpatients seek Alopecia areata treatment from dermatologists in the USA each year. Furthermore, a strong product pipeline, rising disposable incomes, and an increase in the prevalence of chronic diseases that lead to hair loss are expected to propel the segment's growth at the fastest rate during the forecast period.

Which Gender Type Offers the Most Lucrative Opportunities for Alopecia Treatment?

Due to the high prevalence of hair loss in the male population worldwide, the market revenue through male Alopecia treatment dominated in 2021. The most common type of Alopecia Treatment in men is androgenetic Alopecia Treatment. A study cited that around 50% of men in their 50s will experience loss of hair, with androgenetic blading accounting for more than 95% of cases.

The female Alopecia Treatment market, on the other hand, is expected to grow at the fastest rate during the forecast period. The market is expected to grow due to rising awareness, lifestyle changes, increased PCOS levels, and a growing trend in cosmetic procedures.

Hair loss affects about one-third of women at some point in their lives. Hair thinning or bald spots affect up to two-thirds of postmenopausal women. Women's hair loss has a greater impact than men's hair loss because it is less socially acceptable for them. The most common cause of hair loss in women is androgenetic Alopecia Treatment. Alopecia Treatment can have a significant impact on a woman's emotional health and quality of life.

Competitive Analysis

iRestore Hair Growth System, iGrow Laser, Theradome, Curallux, LLC, and LUTRONIC are some of the leading players in the Alopecia treatment market. Players in the market are increasingly forming partnerships and licensing agreements to further refine their product lines and expand their operations. For instance, in China, the Central Pharmaceuticals Group partnered with the iGrow laser system.

China Central Pharmaceuticals has exclusive rights to Aspira in China, and Capillus, LLC has partnered with Svenson, a hair loss treatment clinic, to set up distribution rights for laser therapy caps in Europe, Asia-Pacific, and Australia. The expansion with business partners and local associates is anticipated to heighten the utilization of non-toxic hair removal technology.

Some of the recent developments of key Alopecia Treatment providers are as follows:

• In Aug 2021, Pfizer Inc. announced the positive results of Phase 2b 3 ALLEGRO, which evaluated an oral once-a-day Ritlecitinib drug in patients with alopecia areata, an autoimmune disease characterized by hair loss on the scalp and can also affect face and body.
• In March 2020, the USA Food and Drug Administration (FDA) granted Baricitinib Breakthrough Therapy designation for the treatment of Alopecia Treatment Areata (AA), an autoimmune disorder. The designation of Breakthrough Therapy aims to speed up the development and review of drugs that are intended to treat a serious condition.

Similarly, recent developments related to companies Alopecia Treatment Market have been tracked by the team at Future Market Insight, which is available in the full report.

Market Segments Covered in Alopecia Treatment Market Analysis

By Disease Type:

• Alopecia Areata
• Cicatricial Alopecia
• Traction Alopecia
• Alopecia Totalis
• Androgenetic Alopecia
• Alopecia Universalis
• Other Disease Types

By Treatment Type:

• Pharmaceuticals
• Devices

By Gender:

• Male
• Female

By Sales Channel:

• Prescriptions
• OTC

By Region:

• North America
• Latin America
• Europe
• Asia-Pacific excluding Japan (APEJ)
• Middle East and Africa (MEA)

Frequently Asked Questions

How much is the current worth of the Alopecia Treatment Market?

The global Alopecia Treatment Market is worth more than USD 8.4 Billion at present.

What is the sales forecast for Alopecia Treatment Market?

The value of the Alopecia Treatment Market is projected to increase at a CAGR of around 9.5% from 2022 to 2032.

What was the last 5 year’s market CAGR?

The value of the Alopecia Treatment Market increased at a CAGR of around 8.5% from 2017 to 2021.

What is a key trend shaping the Alopecia Treatment Market’s growth?

Technological advancements, improved reimbursement scenarios, and rising healthcare expenditures around the world are all driving the Alopecia Treatment market forward.

At what percentage will Alopecia Treatment Market sales register growth in China?

The market of Alopecia Treatment Market in China is projected to expand at a CAGR of around 10.9 % from 2022 to 2032.

What do statistics for the UK and South Korea reveal?

Both the UK and South Korean market is expected to grow at nearly 10.2% from 2022 to 2032.